A 501(c)(4) nonprofit organization dedicated to advancing legislation and policies aimed at increasing healthy human lifespan, with a focus on accelerating equitable access to next-generation therapies.
Aging is the greatest risk factor for chronic diseases and conditions, but less than 1% of the National Institutes of Health (NIH) budget goes to aging biology research.
A4LI’s inception comes at a pivotal moment when breakthroughs in science and surges in funding have primed the industry for transformation. With an eye on the future, we endeavor to align with healthcare pioneers and thought leaders within the realms of geroscience and policy-making. Our mission is to ensure that the initiatives we advance are strategic and impactful, designed to realize A4LI’s commitment to extending the healthspan of society.
Increased federal funding to accelerate research into therapies that extend healthy lifespans.
We push for clear FDA standards to streamline the approval of safe and effective longevity therapeutics.
Urging Congress to set a national life expectancy goal to drive innovation & improve public health.
Learn about previous impactful events advancing policies promoting healthy human lifespan.
Becoming a member of the Alliance for Longevity Initiatives (A4LI) connects you with a collective voice driving policy change for healthy lifespan extension. Members gain exclusive access to events, expert discussions, and cutting-edge longevity research, while enjoying discounts on health-related products and services. Joining also lets you showcase your support for this vital movement, helping shape a future of longer, healthier lives for all.
A4LI’s inception comes at a pivotal moment when breakthroughs in science and surges in funding have primed the industry for transformation. With an eye on the future, we endeavor to align with healthcare pioneers and thought leaders within the realms of geroscience and policy-making. Our mission is to ensure that the initiatives we advance are strategic and impactful, designed to realize A4LI’s commitment to extending the healthspan of society.
The aging U.S. population faces rising health challenges, with chronic diseases like heart disease, cancer, and Alzheimer’s leading the causes of death. Nearly 68% of adults over 65 live with multiple chronic conditions, emphasizing the growing impact of multi-morbidity. Declining life expectancy further underscores the need for improved healthcare strategies and preventive measures to address these issues and support healthy aging.
As the U.S. population ages, chronic diseases tied to the aging process—such as heart disease, cancer, and Alzheimer’s—continue to dominate public health concerns. Multi-morbidity, or living with multiple chronic conditions, affects a significant majority of older adults, straining healthcare systems. The emerging field of geroscience offers hope by focusing on the biological processes driving aging, aiming to delay disease onset and enhance overall healthspan. These innovations are crucial in addressing the health challenges of an aging nation.
While the NIH allocates over $1.1 billion annually to aging-related research, less than 10% focuses on the fundamental biology of aging. Meanwhile, private sector investments in longevity biotech are accelerating, surpassing $3 billion in 2023 to advance breakthroughs like regenerative medicine and gene therapy.
Join the Alliance for Longevity Initiatives (A4LI) in advocating for policies that promote healthy human lifespans. Engage by volunteering, signing petitions, or participating in events to support longevity research and equitable access to next-generation therapies.
The Alliance for Longevity Initiatives (A4LI) is a 501(c)(4) nonprofit organization whose mission is to advance legislation and policies that aim to increase healthy human lifespan, with a focus on accelerating equitable access to next-generation therapies.